News
Sinclair Pharma PLC - Final Results
·Sales of £45.3 million representing growth of 20%. o Silhouette Soft ® sales up 12% to £15.7 million. o Silhouette Instalift™ sales of £5.2 million.
·Sales of £45.3 million representing growth of 20%. o Silhouette Soft ® sales up 12% to £15.7 million. o Silhouette Instalift™ sales of £5.2 million.